Summary
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
Register to download
Persistence Leads To High Enrollment
You may also be interested in:
page
The Center for Immuno-oncology, Cellular, and Gene Therapy
We provide end-to-end support for your complex, fast-paced immunotherapy studies.
Read More
Newsletter
Industry Watch
In the second week of July, we bring you news of developments in HIV research, as well as updates on immunotherapies, Alzheimer’s disease,…
Read More
Fact Sheet
The Center for Immuno-oncology, Cellular, and Gene Therapy Fact Sheet
The Center for Immuno-oncology, Cellular, and Gene Therapy leverages our comprehensive experience and cross-functional experts to build…
View Resource
View all related content and resources for Immunology
Explore Insights